It’s the last issue of Pharmaceutical Technology Focus in 2022, and a lot of changes have occurred over the year, not just in the pharma space, but also from a geopolitical, financial and energy perspective.
Most recently, after a tumultuous 45 days, Liz Truss resigned as the UK’s prime minister paving the way for Rishi Sunak to take on the mantle. In this issue, we talk to different stakeholders in the pharmaceutical space to gauge what the sector is hoping Sunak achieves in his tenure when it comes to funding, regulation, and relations with the European Union.
Drug shortages continue to affect medical care in healthcare systems, and experts tell us that supply bottlenecks for cardiovascular drugs are particularly concerning. Also in this issue, we explore how European countries plan to use electronic health records to improve health-related decision-making.
Click here to view the latest issue of Pharmaceutical Technology Focus.